Cryotherapy for Neuropathy in Children
Effect of Cryotherapy in Controlling Peripheral Neuropathy in Cancer Children
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Feb 2022
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 16, 2020
CompletedFirst Posted
Study publicly available on registry
September 2, 2020
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2022
CompletedOctober 15, 2021
October 1, 2021
5 months
August 16, 2020
October 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Nerve conduction studies (NCS)
nerve conduction velocity for sensory ulnar nerve
nerve conduction velocity for sensory ulnar nerve at day 0
Nerve conduction studies (NCS)
nerve conduction velocity for sensory ulnar nerve
nerve conduction velocity for sensory ulnar nerve at day 90
Nerve conduction studies (NCS)
nerve conduction velocity for sensory median nerve
nerve conduction velocity for sensory sensory median nerve at day 0
Nerve conduction studies (NCS)
nerve conduction velocity for sensory median nerve
nerve conduction velocity for sensory sensory median nerve at day 90
Nerve conduction studies (NCS)
nerve conduction velocity for sensory sural nerve
nerve conduction velocity for sensory sural nerve at day 0
Nerve conduction studies (NCS)
nerve conduction velocity for sensory sural nerve
nerve conduction velocity for sensory sural nerve at day 90
Nerve conduction studies (NCS)
nerve conduction velocity for motor common peroneal nerve
nerve conduction velocity for motor common peroneal nerve at day 0
Nerve conduction studies (NCS)
nerve conduction velocity for motor common peroneal nerve
nerve conduction velocity for motor common peroneal nerve at day 90
Study Arms (2)
the study group
EXPERIMENTALGroup (A) the study group received cryotherapy
the control group
NO INTERVENTIONGroup (B) the control group not received cryotherapy
Interventions
Cryotherapy is a pain treatment that uses a method of localized freezing temperatures to deaden an irritated nerve. Cryotherapy is also used as a method of treating localized areas of some cancers (called cryosurgery), such as prostate cancer and to treat abnormal skin cells by dermatologists
Eligibility Criteria
You may qualify if:
- Their age will ranging from eight to seventeen years.
- Children participated in this study will from both sexes.
- Children receiving chemotherapy as medical treatment protocol
- All children have polyneuropathy caused by chemotherapy.
You may not qualify if:
- Children with Epilepsy.
- Children with blood clotting disorder.
- Children have Open wounds / broken skin
- Children with severe cardiac disease
- Uncooperative patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Valley University, Faculty of Physical Therapy
Qina, 83523, Egypt
Related Publications (6)
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014 Dec;155(12):2461-2470. doi: 10.1016/j.pain.2014.09.020. Epub 2014 Sep 23.
PMID: 25261162BACKGROUNDHershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL; American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14.
PMID: 24733808BACKGROUNDScotte F, Banu E, Medioni J, Levy E, Ebenezer C, Marsan S, Banu A, Tourani JM, Andrieu JM, Oudard S. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer. 2008 Apr 1;112(7):1625-31. doi: 10.1002/cncr.23333.
PMID: 18286527BACKGROUNDHanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H, Tsuboyama T. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. J Natl Cancer Inst. 2018 Feb 1;110(2):141-148. doi: 10.1093/jnci/djx178.
PMID: 29924336BACKGROUNDTsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T. Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group. Breast Cancer Res Treat. 2016 Nov;160(1):61-67. doi: 10.1007/s10549-016-3977-7. Epub 2016 Sep 12.
PMID: 27620884BACKGROUNDKadakia KC, Rozell SA, Butala AA, Loprinzi CL. Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage. 2014 Jun;47(6):1100-15. doi: 10.1016/j.jpainsymman.2013.07.014. Epub 2013 Nov 7.
PMID: 24210702BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nehad A. Abo-zaid, Ph.D
South Valley University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Single (Outcomes Assessor) Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group A (control group) and Group B (study group).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of physical therapy, Department of Physical Therapy for Pediatrics, Faculty of Physical Therapy, South Valley University, Qena, Egypt.
Study Record Dates
First Submitted
August 16, 2020
First Posted
September 2, 2020
Study Start
February 1, 2022
Primary Completion
June 30, 2022
Study Completion
July 15, 2022
Last Updated
October 15, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share